These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4377134)

  • 21. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    Arrigo F; Vitale D; Consolo F
    Clin Ter; 1974 Dec; 71(5):459-68. PubMed ID: 4452226
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characterization of pre-beta hyperlipoproteinemias using 3 methods of electrophoresis].
    Michaux A; Rouffy J; Loeper J; Dreux C
    Ann Biol Clin (Paris); 1973; 31(2):95-6. PubMed ID: 4356119
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma lipids and lipoproteins in treated diabetics.
    Retnam VJ; Nerurkar SV; Gupte MH; Bhandarkar SD; Taskar SP
    J Postgrad Med; 1983 Oct; 29(4):193-200. PubMed ID: 6672177
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperlipidemia.
    Sloan RW
    Am Fam Physician; 1983 Sep; 28(3):171-82. PubMed ID: 6613796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secholex, Clofibrate and taurine in hyperlipidaemia.
    Howard AN; Evans RJ
    Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405
    [No Abstract]   [Full Text] [Related]  

  • 27. [Alpha-cholesterol (HDL-cholesterol) and other serum lipid fractions in subjects of low socioeconomic level with healed myocardial infarct].
    Giannini SD; Forti N; Di Rienzo F; Netto MP; Adler R; Almeida A
    Arq Bras Cardiol; 1983 Jun; 40(6):371-5. PubMed ID: 6667146
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    Sommariva D; Scotti L; Baroni L; Beggi P; Fasoli A
    Clin Ter; 1980 Mar; 92(6):649-55. PubMed ID: 7460493
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of ischemic heart disease with a hypolipoproteinemic drug pericit].
    Britov AN; Shmushkovich BI; Karmanskiĭ IM
    Kardiologiia; 1977 Jun; 17(6):87-91. PubMed ID: 197290
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of bezafibrate on disorders of lipid metabolism].
    Stryjek-Kamińska D; Ilińska-Debniak K; Bartosiewicz W; Szczepanik Z
    Pol Tyg Lek; 1983 Dec; 38(50):1567-71. PubMed ID: 6379618
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of tiadenol on type IIA hyperlipidemias].
    de Gennes JL; Truffert J; Le Quere JM
    Therapie; 1976; 31(4):455-63. PubMed ID: 188209
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of the administration of exogenous phospholipids in dyslipidemic patients].
    Ravielle A; Delise P; Totaro G; Piccolo E
    Clin Ter; 1978 Sep; 86(5):441-9. PubMed ID: 737968
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
    Dunnigan MG; Cochrane MA; Kelly A; Scott JW
    Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical aspects of hyperlipoproteinemia.
    Crepaldi G; Fellin R
    Ann Biol Clin (Paris); 1974; 32(4):309-22. PubMed ID: 4376343
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coenzyme A and dyslipidemia. Note I. Rapid changes in lipid and lipoprotein levels induced with coenzyme A in humans].
    Consolo F; Di Tommaso G; Arrigo F; Trifirò A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1920-6. PubMed ID: 1231873
    [No Abstract]   [Full Text] [Related]  

  • 38. Longitudinal study on hyperlipidaemia and diet in RDT patients.
    Palmo A; Boggio-Bertinet D; Balzola F; Stratta P; Triolo G; Alloatti S; Bosticardo G; Giacchino F; Pagano GF; Levis F
    Minerva Nefrol; 1982; 29(1):29-35. PubMed ID: 7048140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary studies on the effects of CoA administration on plasmatic lipids in man].
    Arrigo F; Vitale D; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):305-10. PubMed ID: 4786567
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma lipids and lipoproteins of fasted ponies.
    Bauer JE
    Am J Vet Res; 1983 Mar; 44(3):379-84. PubMed ID: 6838034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.